Similar articles

• The biotech drug market.

  Lawrence S. Lawrence S. Nat Biotechnol. 2004 Dec;22(12):1496. doi: 10.1038/nbt1204-1496. Nat Biotechnol. 2004. PMID: 15583645 No abstract available.
• Biotech drug market steadily expands.

  Lawrence S. Lawrence S. Nat Biotechnol. 2005 Dec;23(12):1466. doi: 10.1038/nbt1205-1466. Nat Biotechnol. 2005. PMID: 16333279 No abstract available.
• Market watch: Biopharma deal-making in 2014: a record year for M&A value.

  Micklus A, Muntner S. Micklus A, et al. Nat Rev Drug Discov. 2015 Feb;14(2):84-5. doi: 10.1038/nrd4536. Nat Rev Drug Discov. 2015. PMID: 25633786 No abstract available.
• Russia through the prism of the world biopharmaceutical market.

  Bairamashvili DI, Rabinovich ML. Bairamashvili DI, et al. Biotechnol J. 2007 Jul;2(7):801-17. doi: 10.1002/biot.200700091. Biotechnol J. 2007. PMID: 17615600 Review.
• Follow-on biologics: data exclusivity and the balance between innovation and competition.

  Grabowski H. Grabowski H. Nat Rev Drug Discov. 2008 Jun;7(6):479-88. doi: 10.1038/nrd2532. Epub 2008 May 12. Nat Rev Drug Discov. 2008. PMID: 18469828 Review.